CiliaScope - Transforming Respiratory Diagnostics With AI

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

February 28, 2027
Response Due
Active
Status

Opportunity Overview

 
Respiratory cilia are tiny, hair-like structures that line the airways and help keep the lungs healthy by clearing out mucus, dust, and other harmful particles. When these cilia do not function properly, it can lead to a rare genetic condition called Primary Ciliary Dyskinesia (PCD), which affects breathing and lung health.
 
Diagnosing PCD currently involves a slow and labour-intensive process. Specialist clinicians must manually search for cilia in extremely thin tissue samples using a transmission electron microscope (TEM). Because cilia are so small and can appear in many different orientations, clinicians must take many images at different magnifications, identify the right cross-sections, and analyse ~30-50 examples per sample to make an accurate diagnosis. Although machine learning (ML) tools are beginning to assist with diagnosis, image collection and classification are still done manually, creating a bottleneck that limits the speed and scalability of diagnosis.
 
The goal of CiliaScope is to automate the image collection and analysis process by controlling the microscope to scan low-resolution images, locate regions containing cilia, capture high-resolution images of each cilium, and generate fully reproducible diagnostic reports. The full algorithm has been developed, but at the end of our Impact Acceleration Account  project, we encountered an unexpected, high-risk and fundamental bottleneck that prevented CiliaScope from functioning as intended. TEMs do not maintain a fixed reference frame when changing magnification, which means that coordinates identified at low magnification do not precisely align with those at high magnification. Unless this problem is solved, CiliaScope cannot operate reliably. Addressing this issue is the central aim of this MRC proposal.
 
If successful, CiliaScope will dramatically reduce the time and cost of diagnosis, release skilled staff for other tasks, and enable microscopes to operate...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedFebruary 28, 2026
Procurement stageActive solicitation
Response dueFebruary 28, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.